1993: GINA is launched under the auspices of the National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), USA (represented by Dr Claude Lenfant), and the World Health Organization (WHO) (represented by Dr Nikolai Khaltaev). Dr Albert L. Sheffer was the chair of this expert panel. |
1995: Publication of the first GINA Report: “Global Strategy for Asthma Management and Prevention: NHLBI/WHO Workshop Report”. |
2000: A Science Committee is constituted to prepare the first major revision of the 1995 report (released in 2002). Since 2002, the GINA Report has been revised annually. |
2001: GINA initiates an annual World Asthma Day to raise awareness about the burden of asthma. |
2002: The GINA Report states that it is reasonable to expect that in most patients with asthma, control of the disease can and should be achieved and maintained. |
2004: A “Dissemination Committee” is formed (First Chair: Dr Wan-Cheng Tan). This Committee will a few years later become the “Dissemination and Implementation Committee” (First Chair: Dr Louis-Philippe Boulet). |
2005: GINA recommends implementing an approach to asthma management based on asthma control, rather than asthma severity. |
2008: Registration of GINA as a non-profit, tax-exempt organisation under the direction of a Board of Directors. Financial independence achieved in 2014. |
2014: Major revision of the GINA Report, identifying the importance of assessing modifiable risk factors as well as symptom control, and incorporating practical flow-charts and tables to increase utility of the report for clinical practice. |
2015: Dr Claude Lenfant and Dr Suzanne Hurd retire from GINA. Ms Rebecca Decker becomes the GINA Program Director. |
2019: Major revision of the GINA Report. On demand short-acting β2-agonists are no longer recommended as a sole asthma treatment, even for the mildest forms of asthma. |